CA2985090C - Application medicales et veterinaires de lumiere a des composes therapeutiques - Google Patents
Application medicales et veterinaires de lumiere a des composes therapeutiques Download PDFInfo
- Publication number
- CA2985090C CA2985090C CA2985090A CA2985090A CA2985090C CA 2985090 C CA2985090 C CA 2985090C CA 2985090 A CA2985090 A CA 2985090A CA 2985090 A CA2985090 A CA 2985090A CA 2985090 C CA2985090 C CA 2985090C
- Authority
- CA
- Canada
- Prior art keywords
- light
- solution
- fiber optic
- antimicrobial
- optic cable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 38
- 150000001875 compounds Chemical class 0.000 title claims abstract description 14
- 230000002195 synergetic effect Effects 0.000 claims abstract description 32
- 239000007800 oxidant agent Substances 0.000 claims abstract description 16
- 230000002708 enhancing effect Effects 0.000 claims abstract description 5
- 230000000845 anti-microbial effect Effects 0.000 claims description 48
- 239000000126 substance Substances 0.000 claims description 37
- 239000004599 antimicrobial Substances 0.000 claims description 26
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 25
- 230000000118 anti-neoplastic effect Effects 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 9
- 230000000840 anti-viral effect Effects 0.000 claims description 8
- 239000004342 Benzoyl peroxide Substances 0.000 claims description 6
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 6
- 235000019400 benzoyl peroxide Nutrition 0.000 claims description 6
- 229940078916 carbamide peroxide Drugs 0.000 claims description 6
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 6
- 230000003115 biocidal effect Effects 0.000 claims description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 4
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims description 4
- 102000016387 Pancreatic elastase Human genes 0.000 claims description 2
- 108010067372 Pancreatic elastase Proteins 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 108010059820 Polygalacturonase Proteins 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 230000002921 anti-spasmodic effect Effects 0.000 claims description 2
- 229960003260 chlorhexidine Drugs 0.000 claims description 2
- 239000000812 cholinergic antagonist Substances 0.000 claims description 2
- 229960003405 ciprofloxacin Drugs 0.000 claims description 2
- 239000000645 desinfectant Substances 0.000 claims description 2
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 2
- 125000003454 indenyl group Chemical class C1(C=CC2=CC=CC=C12)* 0.000 claims description 2
- 150000002497 iodine compounds Chemical class 0.000 claims description 2
- 230000003637 steroidlike Effects 0.000 claims description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims 1
- 102000003390 tumor necrosis factor Human genes 0.000 claims 1
- 239000000835 fiber Substances 0.000 abstract description 66
- 238000009472 formulation Methods 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 5
- 239000000243 solution Substances 0.000 description 112
- 238000010438 heat treatment Methods 0.000 description 25
- 206010000496 acne Diseases 0.000 description 22
- 208000002874 Acne Vulgaris Diseases 0.000 description 20
- 241001465754 Metazoa Species 0.000 description 20
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 14
- 239000003814 drug Substances 0.000 description 13
- 230000000699 topical effect Effects 0.000 description 12
- 229940079593 drug Drugs 0.000 description 11
- 239000000499 gel Substances 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 9
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 9
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 9
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 8
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 8
- UOBYKYZJUGYBDK-UHFFFAOYSA-N 2-naphthoic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CC=C21 UOBYKYZJUGYBDK-UHFFFAOYSA-N 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 7
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 7
- 229960004889 salicylic acid Drugs 0.000 description 7
- 229960001727 tretinoin Drugs 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 6
- 229910021538 borax Inorganic materials 0.000 description 6
- 239000000969 carrier Substances 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000004328 sodium tetraborate Substances 0.000 description 6
- 235000010339 sodium tetraborate Nutrition 0.000 description 6
- 239000011593 sulfur Substances 0.000 description 6
- 229910052717 sulfur Inorganic materials 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 5
- -1 chlorhexidine compound Chemical class 0.000 description 5
- 229960003512 nicotinic acid Drugs 0.000 description 5
- 230000009885 systemic effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 235000001968 nicotinic acid Nutrition 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 229940034982 antineoplastic agent Drugs 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- UFUVLHLTWXBHGZ-MGZQPHGTSA-N [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](OP(O)(O)=O)[C@@H](SC)O1 UFUVLHLTWXBHGZ-MGZQPHGTSA-N 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229960002227 clindamycin Drugs 0.000 description 2
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 2
- 229960002291 clindamycin phosphate Drugs 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- 230000001613 neoplastic effect Effects 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 229960002446 octanoic acid Drugs 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 229960001755 resorcinol Drugs 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical class CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241001635598 Enicostema Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- 206010027626 Milia Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 208000009621 actinic keratosis Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- XMEVHPAGJVLHIG-FMZCEJRJSA-N chembl454950 Chemical compound [Cl-].C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H]([NH+](C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O XMEVHPAGJVLHIG-FMZCEJRJSA-N 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 230000002925 chemical effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960004989 tetracycline hydrochloride Drugs 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D9/00—Bandages, poultices, compresses specially adapted to veterinary purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0606—Mouth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/063—Radiation therapy using light comprising light transmitting means, e.g. optical fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A61N2005/0652—Arrays of diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Radiation-Therapy Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Laser Surgery Devices (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Abstract
Il est décrit des applications médicales et vétérinaires de la lumière aux composés thérapeutiques comprenant un agent de retenue de solution adapté pour retenir une solution thérapeutique contre un tissu dun utilisateur, un câble à fibres optiques, une source lumineuse qui se connecte au câble à fibres optiques et fournit une lumière dune longueur donde prédéterminée au câble à fibres optiques, et une terminaison lumineuse sur le câble de fibre optique qui expose la lumière à la solution thérapeutique. Une formulation comprend un comburant, la solution thérapeutique ayant une efficacité thérapeutique initiale et une lumière dune fréquence prédéterminée qui subit une réaction synergique avec le comburant, améliorant ainsi lefficacité thérapeutique initiale de la solution.
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462026498P | 2014-07-18 | 2014-07-18 | |
| US62/026,498 | 2014-07-18 | ||
| US14/497,269 | 2014-09-25 | ||
| US14/497,269 US9579177B2 (en) | 2014-07-18 | 2014-09-25 | Dental and medical devices with light source and antimicrobial solution |
| US14/536,633 | 2014-11-09 | ||
| US14/536,633 US9504848B2 (en) | 2014-07-18 | 2014-11-09 | Medical devices with a light source and antimicrobial solution |
| US14/583,580 | 2014-12-26 | ||
| US14/583,580 US9931189B2 (en) | 2014-07-18 | 2014-12-26 | Veterinary devices with a light source and antimicrobial solution |
| US14/630,513 | 2015-02-24 | ||
| US14/630,513 US9700735B2 (en) | 2014-07-18 | 2015-02-24 | Medical and veterinary applications of light to antimicrobial and antineoplastic chemicals |
| US14/638,902 US10016456B2 (en) | 2014-07-18 | 2015-03-04 | Methods for treating acne vulgaris |
| US14/638,902 | 2015-03-04 | ||
| US14/697,579 US20160015745A1 (en) | 2014-07-18 | 2015-04-27 | Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In Combination With Certain Wavelengths of Light |
| US14/697,579 | 2015-04-27 | ||
| CA2954886A CA2954886C (fr) | 2014-07-18 | 2015-07-07 | Application medicales et veterinaires de lumiere a des composes therapeutiques |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2954886A Division CA2954886C (fr) | 2014-07-18 | 2015-07-07 | Application medicales et veterinaires de lumiere a des composes therapeutiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2985090A1 CA2985090A1 (fr) | 2016-01-21 |
| CA2985090C true CA2985090C (fr) | 2023-11-07 |
Family
ID=55079906
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2954886A Active CA2954886C (fr) | 2014-07-18 | 2015-07-07 | Application medicales et veterinaires de lumiere a des composes therapeutiques |
| CA2985090A Active CA2985090C (fr) | 2014-07-18 | 2015-07-07 | Application medicales et veterinaires de lumiere a des composes therapeutiques |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2954886A Active CA2954886C (fr) | 2014-07-18 | 2015-07-07 | Application medicales et veterinaires de lumiere a des composes therapeutiques |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3169400A4 (fr) |
| JP (1) | JP2018501829A (fr) |
| KR (1) | KR20170019383A (fr) |
| CN (1) | CN106659902A (fr) |
| AU (1) | AU2015290092B2 (fr) |
| CA (2) | CA2954886C (fr) |
| WO (1) | WO2016010765A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108853750B (zh) * | 2018-07-16 | 2020-03-20 | 北京大学口腔医学院 | 穿戴式光疗设备 |
| CN109009549B (zh) * | 2018-08-20 | 2024-06-28 | 中国人民解放军军事科学院军事医学研究院 | 记录动物药物成瘾行为及相关脑区神经活动规律的装置 |
| DE102020111257A1 (de) | 2020-04-24 | 2021-10-28 | Jessika Kähler | Anordnung zur Photobiomodulation eines Lebewesens |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4898439A (en) * | 1988-02-10 | 1990-02-06 | Kei Mori | Light radiation device for use in medical treatment |
| AU3578497A (en) * | 1996-08-08 | 1998-03-06 | Light Sciences Limited Partnership | Method and apparatus to treat gingival and periodontal disease |
| US6254391B1 (en) * | 1997-11-22 | 2001-07-03 | Daniel Henry Darnell | Device for heating the teeth and uses therefor |
| CN1269468C (zh) * | 2001-01-29 | 2006-08-16 | 三菱瓦斯化学株式会社 | 牙齿漂白剂和牙齿漂白方法 |
| ATE525095T1 (de) * | 2002-01-08 | 2011-10-15 | Bernard Technologies Inc | Antimikrobielle körperbedeckungsartikel |
| US6893259B1 (en) * | 2004-03-08 | 2005-05-17 | Igor Reizenson | Oral hygiene device and method of use therefor |
| SG140589A1 (en) * | 2004-08-06 | 2008-03-28 | Pharos Life Corp | Therapy device and related accessories, compositions, and treatment methods |
| GB0423332D0 (en) * | 2004-10-21 | 2004-11-24 | Dezac Ltd | Tooth whitening apparatus and methods |
| JP2006271831A (ja) * | 2005-03-30 | 2006-10-12 | Terumo Corp | 医療用治療装置およびその装置の使用方法 |
| AU2006249760C1 (en) * | 2005-05-25 | 2010-11-04 | Biolase, Inc. | Device having activated textured surfaces for treating oral tissue |
| CA2632183A1 (fr) * | 2005-08-25 | 2007-03-01 | Philip R. Houle | Solutions sensibilisantes ameliorees, systemes, et procedes d'utilisation |
| US8057464B2 (en) * | 2006-05-03 | 2011-11-15 | Light Sciences Oncology, Inc. | Light transmission system for photoreactive therapy |
| EP3205355A1 (fr) * | 2008-11-07 | 2017-08-16 | KLOX Technologies, Inc. | Combinaison d'un oxydant et d'un photoactivateur |
| US8771741B2 (en) * | 2009-01-23 | 2014-07-08 | The Penn State Research Foundation | In vivo photodynamic therapy of cancer via a near infrared agent encapsulated in calcium phosphate nanoparticles |
| JP2012532103A (ja) * | 2009-06-30 | 2012-12-13 | スリーエム イノベイティブ プロパティズ カンパニー | 光活性化抗菌性物品及び使用方法 |
| JP6246468B2 (ja) * | 2010-03-11 | 2017-12-13 | メルク パテント ゲーエムベーハー | 治療および化粧品におけるファイバー |
| US8591229B2 (en) * | 2010-12-16 | 2013-11-26 | Duane C. Keller | Devices and methods for creating a positive pressure environment for treatment of oral biofilms associated with periodontal disease |
| US20150072302A1 (en) * | 2013-04-19 | 2015-03-12 | Jasibo, LLC. | Light activated tooth whitening composition |
| US20150045720A1 (en) * | 2013-08-08 | 2015-02-12 | A-Z Ltd. | Method for treating local infection |
-
2015
- 2015-07-07 JP JP2017523772A patent/JP2018501829A/ja active Pending
- 2015-07-07 CA CA2954886A patent/CA2954886C/fr active Active
- 2015-07-07 CA CA2985090A patent/CA2985090C/fr active Active
- 2015-07-07 CN CN201580038475.2A patent/CN106659902A/zh active Pending
- 2015-07-07 KR KR1020167036689A patent/KR20170019383A/ko not_active Application Discontinuation
- 2015-07-07 AU AU2015290092A patent/AU2015290092B2/en active Active
- 2015-07-07 EP EP15821889.1A patent/EP3169400A4/fr not_active Withdrawn
- 2015-07-07 WO PCT/US2015/039292 patent/WO2016010765A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| EP3169400A1 (fr) | 2017-05-24 |
| AU2015290092B2 (en) | 2018-08-16 |
| WO2016010765A1 (fr) | 2016-01-21 |
| CN106659902A (zh) | 2017-05-10 |
| KR20170019383A (ko) | 2017-02-21 |
| CA2954886A1 (fr) | 2016-01-21 |
| EP3169400A4 (fr) | 2018-04-11 |
| CA2954886C (fr) | 2020-06-30 |
| JP2018501829A (ja) | 2018-01-25 |
| AU2015290092A1 (en) | 2017-01-12 |
| CA2985090A1 (fr) | 2016-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020103365A4 (en) | Methods for photodynamic therapy | |
| US9884203B2 (en) | Medical and veterinary applications of light to antimicrobial and antineoplastic chemicals | |
| AU750260B2 (en) | Photomatrix device | |
| KR102057349B1 (ko) | 광 조사 기구 | |
| US20160015909A1 (en) | System, retainer and method of providing therapeutic treatment for acne | |
| CA2985090C (fr) | Application medicales et veterinaires de lumiere a des composes therapeutiques | |
| US10293148B2 (en) | System, retainer and method of preventing and treating nosocomial infections including methicillin-resistant Staphylococcus aureus infections | |
| JP2018501829A5 (fr) | ||
| US9504848B2 (en) | Medical devices with a light source and antimicrobial solution | |
| JP2018536028A (ja) | 刺青の退色および除去を行うシステム、装置、および方法 | |
| US20160354407A1 (en) | Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In Combination With Certain Wavelengths of Light | |
| CN105999265A (zh) | 光敏分子的光动力组合在痤疮治疗药物中的应用 | |
| EP3368140A2 (fr) | Système, appareil et procédé permettant d'estomper et d'enlever un tatouage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20200630 |
|
| EEER | Examination request |
Effective date: 20200630 |
|
| EEER | Examination request |
Effective date: 20200630 |
|
| EEER | Examination request |
Effective date: 20200630 |
|
| EEER | Examination request |
Effective date: 20200630 |
|
| EEER | Examination request |
Effective date: 20200630 |
|
| EEER | Examination request |
Effective date: 20200630 |
|
| EEER | Examination request |
Effective date: 20200630 |
|
| EEER | Examination request |
Effective date: 20200630 |
|
| EEER | Examination request |
Effective date: 20200630 |